Who Owns TOVX?

Theriva Biologics, Inc. — Institutional Ownership & 13F Holdings

$0.35

-0.00 (-1.10%)

Market Cap

$12.6M

Shares Outstanding

35,688,349

Institutional Holders

10

Total Inst. Value

$208K

% of Float Held

0.6%

QoQ Holder Change

-12

Institutional data as of Q1 2025

New Positions

4

Closed Positions

3

Increased

1

Decreased

2

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Ikarian Capital, LLCNew$132K120,031
2BOOTHBAY FUND MANAGEMENT, LLCNew$39K35,601
3GEODE CAPITAL MANAGEMENT, LLCNew$19K18,683
4UBS Group AG$9K7,851
5BlackRock, Inc.$8K7,568
6OSAIC HOLDINGS, INC.$972884
7IFP Advisors, Inc$1211
8SBI Securities Co., Ltd.$1110
9Pandora Wealth, Inc.New$44
10BANK OF AMERICA CORP /DE/$041

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
UBS Group AG-9K$9K
OSAIC HOLDINGS, INC.-410$972

Related Stocks

Frequently Asked Questions

How many institutional investors hold TOVX?

As of Q1 2025, 10 institutional investors report holding TOVX (Theriva Biologics, Inc.) in their 13F filings.

What percentage of Theriva Biologics, Inc. is owned by institutions?

Institutional investors hold approximately 0.6% of Theriva Biologics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most TOVX?

The largest institutional holder of TOVX is Ikarian Capital, LLC with $132K in shares.

Are institutions buying or selling TOVX?

This quarter, 4 institutions opened new positions in TOVX and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.